Literature DB >> 9194894

Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy.

K Arima1, M Nakamura, N Sunohara, M Ogawa, M Anno, Y Izumiyama, S Hirai, K Ikeda.   

Abstract

Coiled bodies and interfascicular threads are conspicuous white matter abnormalities of brains of patients with progressive supranuclear palsy (PSP). Both structures are argyrophilic and immunoreactive for the microtubule-binding protein tau. This report concerns the ultrastructural localization of interfascicular threads and their relationship to coiled bodies in five PSP patients. We showed for the first time that abnormal tubules with a 13- to 15-nm diameter and fuzzy outer contours were the common structures of coiled bodies in the oligodendroglial perikarya and of interfascicular threads. Moreover, the tubules were immunolabeled by anti-tau antibodies. The abnormal tau-positive tubules of interfascicular threads were located in the inner loop of the myelin sheath. Our study further indicated that the thread-like structures in the white matter comprised, at least in part, oligodendroglial processes, and that they were also present in gray matter. We consider that the formation of coiled bodies in the perikarya and of interfascicular threads represents a common cytoskeletal abnormality of the oligodendroglia of PSP patients. Moreover, even though the white matter alterations of PSP resemble those of corticobasal degeneration, there are certain ultrastructural differences in the abnormal oligodendroglial tubules of the two diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194894     DOI: 10.1007/s004010050652

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  7 in total

1.  Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies.

Authors:  He-Jin Lee; Ji-Eun Suk; Christina Patrick; Eun-Jin Bae; Ji-Hoon Cho; Sangchul Rho; Daehee Hwang; Eliezer Masliah; Seung-Jae Lee
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

Review 2.  Progressive supranuclear palsy.

Authors:  K Tawana; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

3.  Widespread alterations of alpha-synuclein in multiple system atrophy.

Authors:  D W Dickson; W Liu; J Hardy; M Farrer; N Mehta; R Uitti; M Mark; T Zimmerman; L Golbe; J Sage; A Sima; C D'Amato; R Albin; S Gilman; S H Yen
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

4.  Filamentous aggregations of phosphorylated α-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy.

Authors:  Keiko Nakamura; Fumiaki Mori; Tomoya Kon; Kunikazu Tanji; Yasuo Miki; Masahiko Tomiyama; Hidekachi Kurotaki; Yasuko Toyoshima; Akiyoshi Kakita; Hitoshi Takahashi; Masahito Yamada; Koichi Wakabayashi
Journal:  Acta Neuropathol Commun       Date:  2015-05-21       Impact factor: 7.801

5.  Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX.

Authors:  Toshiki Uchihara; Kentaro Endo; Hiromi Kondo; Sachi Okabayashi; Nobuhiro Shimozawa; Yasuhiro Yasutomi; Eijiro Adachi; Nobuyuki Kimura
Journal:  Acta Neuropathol Commun       Date:  2016-11-14       Impact factor: 7.801

Review 6.  Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.

Authors:  Elisa Canepa; Silvia Fossati
Journal:  Front Neurol       Date:  2021-01-07       Impact factor: 4.003

7.  Latent trait modeling of tau neuropathology in progressive supranuclear palsy.

Authors:  Naomi Kouri; Melissa E Murray; Joseph S Reddy; Daniel J Serie; Alexandra Soto-Beasley; Mariet Allen; Minerva M Carrasquillo; Xue Wang; Monica Casey Castanedes; Matthew C Baker; Rosa Rademakers; Ryan J Uitti; Neill R Graff-Radford; Zbigniew K Wszolek; Gerard D Schellenberg; Julia E Crook; Nilüfer Ertekin-Taner; Owen A Ross; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2021-02-26       Impact factor: 17.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.